Sustaining a bioartificial liver under hypothermic conditions

Pamela H. Lai, Timothy D. Sielaff, Wei Shou Hu

Research output: Contribution to journalArticle

6 Scopus citations

Abstract

Bioartificial liver (BAL) devices employing xenogeneic hepatocytes are being developed as a temporary support of liver failure. For clinical applications, transporting such a device from the manufacturing site to the hospital is necessary. We investigated the effect of hypothermic treatment on the performance of the collagen-entrapment BAL device developed at the University of Minnesota. A number of chemical protectants were examined for their effectiveness in minimizing damage to hepatocytes. Preincubation with protectant (tauroursodeoxycholic acid, TUDCA) before hypothermic treatment improved posttreatment BAL performance. Oxygen consumption and albumin and urea synthesis all resumed at levels comparable to pretreatment levels. The method described will facilitate the application of BAL in the treatment of liver failure.

Original languageEnglish (US)
Pages (from-to)427-437
Number of pages11
JournalTissue Engineering
Volume11
Issue number3-4
DOIs
StatePublished - Mar 1 2005

Fingerprint Dive into the research topics of 'Sustaining a bioartificial liver under hypothermic conditions'. Together they form a unique fingerprint.

  • Cite this